A Chinese biotechnological company announced on Sunday it has developed the world's first 3D blood vessel bio-printer, which makes it possible to produce personalized functional organs. Sichuan Revotek Co., Ltd. based in Chengdu, capital ...
Tags: 3D Blood Vessel, Bio-printer
A Chinese man has donated hemopoietic stem cells (HSCs) to a patient with blood disease in Malaysia. Lu, 22, from south China's Guangxi Zhuang Autonomous Region, signed up to be a stem cell donor with the China Marrow Donor Program (CMDP) ...
Tags: Stem Cells, donor
Stem cells could be future source for 'eco-friendly' meat, a study has found The scientific progress that has made it possible to dream of a future in which faulty organs could be regrown from stem cells also holds potential as an ethical ...
Tags: Agriculture, Food, eco-friendly meat, meat
A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's ...
Tags: Immune System Reconstitutes Itself, Immune-Depleting Therapy
AMSBIO has launched CancerSeq™ - a new range of genetically characterised FFPE tissue samples. CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation ...
Advances in neonatal care for very preterm infants have greatly increased the chances of survival for these fragile infants. However, preterm infants have an increased risk of developing bronchopulmonary dysplasia (BPD), a serious lung ...
Tags: Stem Cell, Preterm Infant, BPD, adverse effect
BrainStorm Cell Therapeutics has received a notice of allowance from the US Patent Office for its ‘Mesenchymal Stem Cells for the Treatment of CNS Diseases’ (serial number 12/994,761) patent application. This patent relates to ...
Tags: Cell Technology Patent, Medicine
A new study has found that adolescents and young adults undergoing cancer treatment gain coping skills and resilience-related outcomes when they participate in a therapeutic music process that includes writing song lyrics and producing ...
German biotechnology company Miltenyi Biotec has received the US Food and Drug Administration's(FDA)approval for its CliniMACS CD34 reagent system to prevent graft-versus-host disease(GVHD)in the treatment of acute myeloid leukemia(AML). ...
Tags: Miltenyi Biotec, Blood, Medicine
In normal development, all cells turn off genes they don’t need, often by attaching a chemical methyl group to the DNA, a process called methylation. Historically, scientists believed methyl groups could only stick to a particular DNA ...
Tags: new gene control mechanism, nervous system disorder, health
Stem cells can turn into heart cells, skin cells can mutate to cancer cells; even cells of the same tissue type exhibit small heterogeneities. Scientists use single-cell analysis to investigate these heterogeneities. But the method is still ...
Tags: Consumer Electronics, Electronics, Biological Single-Cell
Living cells are ready for their close-ups, thanks to a new imaging technique that needs no dyes or other chemicals, yet renders high-resolution, three-dimensional, quantitative imagery of cells and their internal structures – all ...
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery? version 1.5 (discovery.lifemapsc.com). LifeMap Discovery? is a state-of-the-art roadmap of embryonic development and ...
Northstar Global Business Services, Inc., Symbol (OTCPink: MDIN) today announced that it has plans to begin manufacturing a new advanced formula nutrition bar based on it's highly rated workout supplement, Stem-Intense. The product, aptly ...
Tags: stem cell technology, value of the company's portfolio
Signals Potential of Newborn Stem Cells in Regenerative Medicine for Common Disorders Cord Blood Registry® (CBR®), the world's largest and most experienced newborn stem cell company, announces the start of a U.S. Food and Drug ...